Article
Genetic polymorphism directs IL-6 expression in fibroblasts but not selected other cell types.
Proceedings of the National Academy of Sciences of the United States of America - 1 Dec 2015
Noss Erika H, Nguyen Hung N, Chang Sook Kyung, Watts Gerald F M, Brenner Michael B
Abstract excerpt
Interleukin (IL)-6 blockade is an effective treatment for rheumatoid arthritis (RA), and synovial fibroblasts are a major IL-6 producer in the inflamed joint. We found that human RA and osteoarthritis (OA) synovial fibroblasts derived from independent donors reproducibly segregated into low, medium, and high IL-6 producers, independent of stimulus, cell passage, or disease state. IL-6 expression pattern...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
